Research Article
Changes in miRNA Gene Expression during Wound Repair in Differentiated Normal Human Bronchial Epithelium
Table 2
The results of pathway analysis of predicted target genes for profile 9 in DAVID database.
| Category | Pathway | Enrichment score | No. of genes | | (FDR corrected) |
| KEGG | Pathways in cancer | 1.4 | 259 | 5.70E − 17 | 1.40E − 13 | KEGG | PI3K-Akt signaling pathway | 1.4 | 221 | 1.90E − 12 | 2.60E − 09 | KEGG | MAPK signaling pathway | 1.5 | 170 | 7.80E − 12 | 1.00E − 08 | KEGG | Focal adhesion | 1.5 | 141 | 3.40E − 11 | 4.50E − 08 | KEGG | Axon guidance | 1.6 | 92 | 1.50E − 09 | 2.00E − 06 | KEGG | Ras signaling pathway | 1.4 | 146 | 7.30E − 09 | 9.70E − 06 | KEGG | cGMP-PKG signaling pathway | 1.5 | 111 | 3.90E − 08 | 5.20E − 05 | KEGG | Rap1 signaling pathway | 1.4 | 135 | 4.50E − 08 | 6.00E − 05 | KEGG | Proteoglycans in cancer | 1.4 | 129 | 7.00E − 08 | 9.40E − 05 | KEGG | FoxO signaling pathway | 1.5 | 92 | 1.00E − 07 | 1.40E − 04 | KEGG | Regulation of actin cytoskeleton | 1.4 | 133 | 3.10E − 07 | 4.10E − 04 | KEGG | Signaling pathways regulating pluripotency of stem cells | 1.5 | 94 | 3.70E − 07 | 4.90E − 04 | KEGG | T cell receptor signaling pathway | 1.6 | 73 | 3.90E − 07 | 5.30E − 04 | KEGG | Adrenergic signaling in cardiomyocytes | 1.5 | 97 | 5.00E − 07 | 6.60E − 04 | KEGG | Melanoma | 1.7 | 54 | 5.00E − 07 | 6.70E − 04 | KEGG | cAMP signaling pathway | 1.4 | 125 | 6.50E − 07 | 8.70E − 04 | KEGG | Glutamatergic synapse | 1.5 | 78 | 1.40E − 06 | 1.90E − 03 | KEGG | Wnt signaling pathway | 1.4 | 91 | 1.90E − 06 | 2.60E − 03 | KEGG | HTLV-I infection | 1.3 | 154 | 2.10E − 06 | 2.80E − 03 | KEGG | Dopaminergic synapse | 1.5 | 85 | 2.90E − 06 | 3.90E − 03 | KEGG | Renal cell carcinoma | 1.7 | 49 | 3.00E − 06 | 3.90E − 03 | KEGG | Neurotrophin signaling pathway | 1.5 | 80 | 4.70E − 06 | 6.30E − 03 | KEGG | TNF signaling pathway | 1.5 | 72 | 5.70E − 06 | 7.60E − 03 | KEGG | ErbB signaling pathway | 1.5 | 61 | 7.30E − 06 | 9.80E − 03 | KEGG | Sphingolipid signaling pathway | 1.4 | 79 | 1.10E − 05 | 1.50E − 02 | KEGG | Prostate cancer | 1.5 | 61 | 1.30E − 05 | 1.70E − 02 | KEGG | Insulin signaling pathway | 1.4 | 88 | 2.10E − 05 | 2.80E − 02 | KEGG | Inflammatory mediator regulation of TRP channels | 1.5 | 66 | 2.30E − 05 | 3.00E − 02 | KEGG | Dorsoventral axis formation | 2 | 24 | 2.30E − 05 | 3.10E − 02 | KEGG | Pancreatic cancer | 1.6 | 47 | 3.00E − 05 | 4.10E − 02 | KEGG | Glioma | 1.6 | 47 | 3.00E − 05 | 4.10E − 02 | KEGG | Oxytocin signaling pathway | 1.4 | 98 | 3.50E − 05 | 4.70E − 02 | KEGG | Platelet activation | 1.4 | 83 | 3.50E − 05 | 4.70E − 02 | KEGG | Insulin resistance | 1.4 | 71 | 3.60E − 05 | 4.80E − 02 |
|
|
Number of predicted target genes that are involved in the particular pathway. |